Introduction to the Route 92 Reperfusion System in Stroke Care

The clinical management of acute ischemic stroke (AIS) caused by large vessel occlusion (LVO) has undergone a revolutionary shift, especially with the introduction of the Route 92 Reperfusion System. Historically, endovascular thrombectomy (EVT) relied on standard aspiration catheters and stent retrievers. However, many clinicians found that achieving the first-pass effect (FPE) remained challenging with traditional tools. The introduction of super large-bore aspiration catheters has significantly addressed these limitations by providing higher suction forces and better clot integration. Specifically, the Route 92 Reperfusion System utilizes advanced delivery mechanisms to navigate tortuous vascular anatomy while maintaining a large internal diameter. This system aims to maximize the probability of successful reperfusion in a single pass. Consequently, neurologists and interventional radiologists are increasingly looking toward these specialized systems to improve functional outcomes. Furthermore, the ability to achieve rapid recanalization is critical because 'time is brain' in the context of ischemic events. In addition, recent data suggests that the mechanical efficiency of super large-bore systems might reduce the risk of distal embolization. Therefore, understanding the pooled efficacy of this system is essential for contemporary stroke practice in India and globally.

Technical Features of the Route 92 Reperfusion System

The Route 92 Reperfusion System distinguishes itself through several unique engineering features designed for the neurovasculature. Most notably, the system utilizes a 0.088-inch super large-bore aspiration catheter. This increased diameter creates a larger surface area for thrombus ingestion, which translates into higher aspiration forces compared to standard 0.070 or 0.074-inch catheters. Moreover, the system incorporates a specialized delivery catheter or base catheter that provides robust support during the navigation of the distal internal carotid artery. This structural integrity is vital when treating occlusions in the M1 or M2 segments of the middle cerebral artery. Additionally, the transition between the catheter tip and the delivery wire is optimized to minimize the 'ledge effect,' which often hinders catheter advancement over the ophthalmic artery. Because the system facilitates smoother navigation, interventionalists can reach the occlusion site more rapidly. Specifically, the Monopoint technology associated with this system simplifies the overall procedure by reducing the number of manual exchanges required. Consequently, the streamlined workflow potentially reduces procedure times. Furthermore, the larger lumen allows for the effective removal of high-burden red-cell-rich clots that might otherwise fragment under lower suction pressures. Ultimately, these technical advancements aim to provide a more predictable and efficient thrombectomy experience.

Meta-Analysis Methodology and Patient Demographics

To evaluate the real-world performance of the Route 92 Reperfusion System, researchers conducted a comprehensive systematic review and meta-analysis. They searched five major databases through December 2025 to capture all relevant clinical data. Ultimately, seven studies involving 490 patients met the rigorous inclusion criteria. Most of these patients presented with severe neurological deficits, as indicated by their baseline National Institutes of Health Stroke Scale (NIHSS) scores. The meta-analysis utilized random-effects models to account for potential heterogeneity across different clinical settings. Specifically, the primary endpoints focused on the first-pass effect and functional independence at the 90-day follow-up. In addition, the researchers analyzed safety metrics such as symptomatic intracranial hemorrhage and mortality rates. Notably, this analysis included both single-arm studies and comparative cohorts. By aggregating data from diverse centers, the study provides a robust overview of how the system performs across various operator experience levels. Furthermore, the inclusion of comparative data allowed for a direct assessment of risk differences between Route 92 and conventional techniques. Consequently, the findings offer a high level of evidence that can guide institutional procurement and clinical protocols in stroke centers.

Comparing First-Pass Effect and Reperfusion Rates

The meta-analysis revealed that the Route 92 Reperfusion System achieved significantly higher rates of successful reperfusion compared to traditional aspiration techniques. For instance, the comparative analysis showed a risk difference of 0.18 for the first-pass effect, favoring the Route 92 system. This translates to a number needed to treat (NNT) of six, suggesting that for every six patients treated with this system, one additional patient achieves FPE who would not have with other methods. Moreover, the system demonstrated a risk difference of 0.23 for near-complete reperfusion, which corresponds to an mTICI score of 2c or higher. This result is particularly important because near-complete reperfusion is strongly associated with better long-term recovery. Specifically, the single-arm analysis found that 56% of patients achieved FPE, while a staggering 94% achieved near-complete to complete reperfusion. These figures represent a notable improvement over historical benchmarks for standard aspiration catheters. Furthermore, the p-values for these findings were highly significant, reaching 0.001 and 0.0005 respectively. Therefore, the data suggests that the super large-bore design effectively captures the thrombus in a single attempt more frequently. In addition, the consistency of these results across the included studies reinforces the reliability of the system's performance in varied clinical scenarios.

Long-term Functional Outcomes and NIHSS Scores

Beyond immediate technical success, the meta-analysis focused on how the Route 92 Reperfusion System impacts patient recovery. Specifically, the researchers assessed functional independence using the modified Rankin Scale (mRS). The results indicated that 43% of patients achieved an mRS score of 0-2 at the 90-day follow-up. This percentage is highly favorable considering the severity of large vessel occlusions. Additionally, the study observed a significant improvement in neurological status, with NIHSS scores decreasing by a mean difference of 9.55 points. This substantial reduction in stroke severity highlights the clinical benefit of rapid and complete recanalization. Furthermore, the analysis demonstrated that successful reperfusion achieved with this system directly correlates with reduced disability. Consequently, clinicians can feel more confident that the technical advantages of the super large-bore catheter translate into meaningful clinical improvements. In addition, the meta-analysis suggests that the system's efficiency might play a role in reducing the length of hospital stay by preventing secondary complications. Therefore, the high rate of functional independence supports the use of this system as a primary strategy in LVO management. Ultimately, these outcomes emphasize the importance of selecting devices that not only open the vessel but do so efficiently to preserve viable brain tissue.

Safety Evaluation and Clinical Implications in India

Safety remains a paramount concern when introducing larger devices into the delicate neurovasculature. However, the meta-analysis confirmed that the Route 92 Reperfusion System maintains a favorable safety profile. The pooled symptomatic intracranial hemorrhage (sICH) rate was only 3%, which is well within the acceptable limits for endovascular procedures. Moreover, the mortality rate stood at 20%, a figure consistent with the high-risk nature of AIS-LVO populations. Notably, the study found no significant increase in adverse events when compared to standard-sized catheters. This suggests that the 0.088-inch diameter does not necessarily increase the risk of vessel wall injury or perforation when handled by trained specialists. Furthermore, for the Indian healthcare context, where stroke burden is high and resources can be limited, the NNT of 4 for near-complete reperfusion suggests high value. Although the initial cost of super large-bore systems may be higher, the potential for reduced procedure time and improved functional recovery could offset overall costs. Specifically, achieving better outcomes in fewer passes reduces the need for additional devices like stent retrievers. Consequently, hospitals in India should consider incorporating these systems into their stroke protocols to optimize patient care. In addition, further training on large-bore navigation will be essential for the growing community of neuro-interventionalists in the country.

Frequently Asked Questions

What is the First-Pass Effect (FPE) and why is it important?

The First-Pass Effect refers to achieving complete or near-complete reperfusion of the occluded vessel in a single attempt with the thrombectomy device. It is a critical metric because patients who achieve FPE generally have significantly better functional outcomes and lower mortality rates compared to those requiring multiple passes.

How does the Route 92 Reperfusion System differ from standard catheters?

The Route 92 Reperfusion System uses a 0.088-inch super large-bore aspiration catheter, which is significantly larger than standard 0.070-0.074-inch models. This design allows for higher suction forces and better clot integration, which increases the likelihood of successful thrombus removal during the first pass without fragmentation.

What were the safety findings regarding the use of this large-bore system?

The meta-analysis indicated a favorable safety profile with a 3% symptomatic intracranial hemorrhage (sICH) rate and a 20% mortality rate. These results are comparable to or better than standard techniques, suggesting that the larger catheter size does not increase procedural risks when used by experienced interventionalists.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Clinicians should rely on their professional judgment and the latest clinical evidence when making treatment decisions. Refer to the latest local and national guidelines for clinical practice.

References

Elmashad A et al. Efficacy of the Route 92 reperfusion system in acute ischemic stroke due to large vessel occlusion: a systematic review and meta-analysis. Neurosurg Rev. 2026 Jul 08. doi: 10.1007/s10143-026-04376-w. PMID: 42418028.